跳至主要内容
临床试验/JPRN-jRCTs071200031
JPRN-jRCTs071200031招募中3 期

Clinical trial about the influence of royal jelly oral intake for endothelial cell function in patients with hemodialysis: Double blind, randomized trial focused on oxidative stress, macrophage activity, and cancer stem cell

Ohba Kojiro0 个研究点目标入组 270 人开始时间: 2020年9月24日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Hemodialysis caused by chronic renal failure
  • 2. Over 24 months survival after the treatment is expected.
  • 3. Performance status is 0 - 2.
  • 4. Age is 20 years and more.
  • 5. Informed consent was obtained by the patient.
  • 6. Understanding of the facts that all examinations, procedure, and treatments caused by hemodialysis were performed by Japan medical care, and that there is no compensation about the symptoms, disease and disorders in this trial.

排除标准

  • 1.Have already intake of royal jelly or bee-original foods
  • 2.Have plan to buy and take of royal jelly in future
  • 3.Have complication of severe blood diseases that are needed the treatment.
  • 4.Have allergy against royal jelly or bee-original foods
  • 5.Have a history of asthma and atopic disease
  • 6.During pregnancy or breast-feeding
  • 7.Principle investigator or co-investigators judged as inappropriate for this study.

研究者

发起方
Ohba Kojiro

相似试验